Sunshine Biopharma (SBFM) Gross Profit (2018 - 2026)
Sunshine Biopharma's Gross Profit was $2.43 million in Q2 2026, down 29.1% from $3.42 million a year earlier but up 11.3% from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Gross Profit (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Sunshine Biopharma's Gross Profit was $10.71 million through Jun 30, 2026, down 11.6% year-over-year; for FY2025, it was $12.26 million, up 14.9% from FY2024.
- Gross Profit has now increased for three consecutive years, with a five-year compound annual growth rate of 206.2% (FY2020 to FY2025).
- In earlier years, Gross Profit was $10.67 million in FY2024 (+27.9%), $8.34 million in FY2023 (+391.5%), $1.7 million in FY2022 and $110,596 in FY2021 (+142.7%).
- Quarterly Gross Profit has moved between $23,829 (Q4 2021) and $3.42 million (Q2 2025) over five years.
- Compared with a year earlier, Gross Profit has declined for three straight quarters, with growth averaging 10.2% over the last eight quarters.
- The best year-over-year quarter for Gross Profit over five years was Q1 2022 (growth of 191.6%); the worst was Q2 2026 (a decline of 29.1%).
- Per Business Quant data, SBFM's Gross Profit in the three quarters before Q2 2026 was $2.18 million (Q1 2026), $3.03 million (Q4 2025) and $3.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Sunshine Biopharma | 1.05 Mn | -38.04 Mn | 2.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.43 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 3.03 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Jun 30, 2025 | 3.42 Mn |
| Mar 31, 2025 | 2.73 Mn |
| Dec 31, 2024 | 3.09 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.36 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Dec 31, 2023 | 2.57 Mn |
| Sep 30, 2023 | 1.99 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 1.49 Mn |
| Sep 30, 2022 | 67,025.00 |
| Jun 30, 2022 | 75,624.00 |
| Mar 31, 2022 | 62,800.00 |
| Dec 31, 2021 | 23,829.00 |
| Sep 30, 2021 | 30,870.00 |
API Access
Sunshine Biopharma Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();